64 related articles for article (PubMed ID: 3669764)
1. Saturation index of blood cell membrane fatty acids before and after IFN treatment in hairy cell leukemia.
Worman CP; Barker WR; Apostolov K
Leukemia; 1987 Apr; 1(4):379-82. PubMed ID: 3669764
[TBL] [Abstract][Full Text] [Related]
2. [Membrane platelet fatty acids: biochemical characterisation of the ischemic cardiovascular disease, characteristics of the paediatric age, through an artificial neural network interpretation].
Cocchi M; Tonello L; Cappello G; Tarozzi G; Nabacino L; Pastorini E; Bucciarelli S; Solazzo L; De Luca M; Visci G; Caramia G
Pediatr Med Chir; 2008; 30(1):25-30. PubMed ID: 18491675
[TBL] [Abstract][Full Text] [Related]
3. Erythrocyte stearic to oleic acid ratio in patients with ocular melanoma.
Aclimandos WA; Heinemann D; Kelly SB; Sheraidah GA; Hungerford JL
Eye (Lond); 1992; 6 ( Pt 4)():416-9. PubMed ID: 1478318
[TBL] [Abstract][Full Text] [Related]
4. [Fatty acid composition of phospholipids of erythrocyte membranes and risk of breast cancer].
Zaridze DG; Shevchenko VE; Levchuk AA; Lifanova EE
Vopr Onkol; 1990; 36(12):1442-8. PubMed ID: 2126901
[TBL] [Abstract][Full Text] [Related]
5. Hairy cell leukemia: an interferon deficient disease?
Hofmann V; Fehr J; Sauter C; Ottino J
Cancer Treat Rev; 1985 Dec; 12 Suppl B():33-7. PubMed ID: 3833328
[TBL] [Abstract][Full Text] [Related]
6. Reduction in the stearic to oleic acid ratio in the circulating red blood cells: a possible tumour marker in solid human neoplasms.
Wood CB; Habib NA; Apostolov K; Kersten D; Barker W; Smadja C; Thompson A; Blount M
Eur J Surg Oncol; 1985 Jun; 11(2):167-9. PubMed ID: 4007173
[TBL] [Abstract][Full Text] [Related]
7. Erythrocyte stearic to oleic acid ratio in prostatic carcinoma.
Persad RA; Gillatt DA; Heinemann D; Habib NA; Smith PJ
Br J Urol; 1990 Mar; 65(3):268-70. PubMed ID: 2337746
[TBL] [Abstract][Full Text] [Related]
8. Erythrocyte membrane stearic and oleic acid ratios in breast cancer.
Thomas BS; O'Dea J; Fentiman IS
Br J Surg; 1988 Nov; 75(11):1078-9. PubMed ID: 3208038
[TBL] [Abstract][Full Text] [Related]
9. Reduction in the stearic to oleic acid ratio in leukaemic cells--a possible chemical marker of malignancy.
Apostolov K; Barker W; Catovsky D; Goldman J; Matutes E
Blut; 1985 Jun; 50(6):349-54. PubMed ID: 3859340
[TBL] [Abstract][Full Text] [Related]
10. Mid-term observations on the efficacy of alpha-interferon in hairy cell leukemia and status of the interferon system of patients in remission.
Quesada JR; Lepe-Zuniga JL; Gutterman JU
Leukemia; 1987 Apr; 1(4):317-9. PubMed ID: 3669753
[TBL] [Abstract][Full Text] [Related]
11. Hairy cell leukemia with ultrastructural finding of 'tubuloreticular inclusions' in hairy cells: a possible marker of a virus-induced disease?
Mantovani G; Santa Cruz G; Piso A; Arangino V; Balestrieri A; Del Giacco GS
J Submicrosc Cytol; 1986 Jul; 18(3):617-24. PubMed ID: 3746974
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic effect of interferon-alpha on hairy cell leukemia].
Abe Y; Sakai K; Igarashi T; Ishibashi T; Shiga T; Uchida T; Kariyone S
Rinsho Ketsueki; 1989 Apr; 30(4):535-40. PubMed ID: 2769975
[TBL] [Abstract][Full Text] [Related]
13. Alpha interferon for induction of remission in hairy-cell leukemia.
Quesada JR; Reuben J; Manning JT; Hersh EM; Gutterman JU
N Engl J Med; 1984 Jan; 310(1):15-8. PubMed ID: 6689734
[TBL] [Abstract][Full Text] [Related]
14. [Changes in the fatty acid composition of erythrocyte and platelet membranes after diet therapy in patients with hyperlipoproteinemia type II].
Korf II; Meshcheriakova VA; Samsonov MA; Chepurnenko NV; Koshechkin VA
Vopr Med Khim; 1987; 33(3):73-7. PubMed ID: 3630021
[TBL] [Abstract][Full Text] [Related]
15. Reconstitution of endogenous interferon a by recombinant interferon in hairy cell leukemia.
Shehata M; Schwarzmeier JD; Nguyen ST; Hilgarth M; Berger R; Hubmann R; Kickmaier S; Decker T
Cancer Res; 2000 Oct; 60(19):5420-6. PubMed ID: 11034083
[TBL] [Abstract][Full Text] [Related]
16. Changes in peripheral blood and bone marrow specimens during and after alpha 2b-interferon therapy for hairy cell leukemia.
Bardawil RG; Ratain MJ; Golomb HM; Bitter MA; Groves C; Vardiman JW
Leukemia; 1987 Apr; 1(4):340-3. PubMed ID: 3669760
[TBL] [Abstract][Full Text] [Related]
17. Effect of interferon therapy on fatty acid saturation index in hepatitis C virus infection.
Abdel Aziz MT; Abdel-Ghaffar Y; Fouad HH; Abdel Aziz DM; el-Magd AA
East Mediterr Health J; 2001; 7(4-5):779-86. PubMed ID: 15332779
[TBL] [Abstract][Full Text] [Related]
18. B-cell growth factor-induced and alpha-interferon-inhibited proliferation of hairy cells coincides with modulation of cell surface antigens.
Gamliel H; Brownstein BH; Gurfel D; Wu SH; Rosner MC; Golomb HM
Cancer Res; 1990 Jul; 50(13):4111-20. PubMed ID: 2354460
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
[TBL] [Abstract][Full Text] [Related]
20. Desaturation-producing factor present in the tissue, blood, and urine of cancer patients.
Habib NA; Wood CB; Apostolov K; Thompson A; Barker W; Mentha G; Coutilno J; Hershman M
Cancer Detect Prev; 1987; 10(1-2):57-61. PubMed ID: 3568009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
